DNA topoisomerase II cleavage of telomeres in vitro and in vivo

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1395, Issue 1, 1998, Pages 110-120

  Yoon, Hee Jei ^a   Choi, In Young ^a   Kang, Mi Ran ^a   Kim, Soung Soo ^a   Muller, Mark T ^b   Spitzner, Jeffrey R ^b   Chung, In Kwon ^a  

^a Yonsei University   (South Korea)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Antitumor drug; DNA topoisomemse II; Etoposide; Telomeric DNA; Topoisomerase II consensus sequence

Indexed keywords

AMSACRINE; DAUNORUBICIN; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; ELLIPTICINE; ETOPOSIDE; GENISTEIN; POISON;

ARTICLE; CONTROLLED STUDY; DNA CLEAVAGE; DNA PROTEIN COMPLEX; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; TANDEM REPEAT; TELOMERE;

DNA; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; ETOPOSIDE; HELA CELLS; HUMANS; REPETITIVE SEQUENCES, NUCLEIC ACID; SEQUENCE ANALYSIS, DNA; TELOMERE;

EID: 0032491903     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4781(97)00139-5     Document Type: Article

References (41)

1. [1] E.H. Blackburn, Structure and function of telomeres, Nature 350 (1991) 569-573.
2. [2] C.W. Greider, Telomere length regulation, Annu. Rev. Biochem. 65 (1996) 337-365.
3. [3] C.M. Counter, A.A. Avilion, C.E. LeFeuvre, N.N. Stewart, C.W. Greider, C.B. Harley, S. Bacchetti, Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity, EMBO J. 11 (1992) 1921-1929.
4. [4] R.C. Allsopp, H. Vaziri, C. Patterson, S. Goldstein, E.V. Younglai, A.B. Futcher, C.W. Greider, C.B. Harley, Telomere length predicts replicative capacity of human fibroblasts, Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 10114-10118.
5. [5] C.B. Harley, A.B. Futcher, C.W. Greider, Telomeres shorten during ageing of human fibroblasts, Nature 345 (1990) 458-460.
6. [6] C.B. Harley, N.W. Kim, Telomerase and cancer, in: V.T. DeVita, S. Hellman, S.A. Rosenberg (Eds.), Important Advances in Oncology, Lippincott-Raven Publishers, Philadelphia, 1996, pp. 57-67.
7. [7] C.B. Harley, B. Villeponteau, Telomeres and telomerase in ageing and cancer, Curr. Opin. Genet. Dev. 5 (1995) 249-255.
8. [8] V.L. Makarov, Y. Hirose, J.P. Langmore, Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening, Cell 88 (1997) 657-666.
9. [9] C.M. Counter, F.M. Botelho, P. Wang, C.B. Harley, S. Bacchetti, Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes, J. Virol. 68 (1994) 3410-3434.
10. [10] C.M. Counter, H.W. Hirte, S. Bacchetti, C.B. Harley, Telomerase activity in human ovarian carcinoma, Proc. Natl. Acad. Sci. U.S.A 91 (1994) 2900-2904.
11. [11] N.W. Kim, M.A. Piatyszek, K.R. Prowse, C.B. Harley, M.D. West, P.L.C. Ho, G.M. Coviello, W.E. Wright, S.L. Weinrich, J.W. Shay, Specific association of human telomerase activity with immortal cells and cancer, Science 266 (1994) 2011-2015.
12. [12] T.M. Bryan, A. Englezou, J. Gupta, S. Bacchetti, R.R. Reddel, Telomere elongation in immortal human cells without detectable telomerase activity, EMBO J. 14 (1995) 4240-4248.
13. [13] J.S. King, C.F. Fairley, W.F. Morgan, DNA end joining by the Klenow fragment of DNA polymerase I, J. Biol. Chem. 271 (1996) 20450-20457.
14. [14] T. de Lange, Human telomeres are attached to the nuclear matrix, EMBO J. 11 (1992) 717-724.
15. [15] P.N. Cockerill, W.T. Garrard, Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites, Cell 44 (1986) 273-282.
16. [16] W.C. Earnshaw, B. Halligan, C.A. Cooke, M.M. Heck, L.F. Liu, Topoisomerase II is structural component of mitotic chromosome scaffolds, J. Cell Biol. 100 (1985) 1706-1715.
17. [17] Y. Bae, I. Kawasaki, H. Ikeda, L.F. Liu, Illegitimate recombination mediated by calf thymus DNA topoisomerase II in vitro, Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 2076-2080.
18. [18] A.O. Sperry, V.C. Blasquez, W.T. Garrard, Dysfunction of chromosomal loop attachment sites: illegitimate recombination linked to matrix association regions, Proc. Natl. Acad. Sci. U.S.A. 68 (1988) 5497-5501.
19. [19] J.C. Wang, DNA topoisomerases, Annu. Rev. Biochem. 65 (1996) 635-692.
20. [20] S. DiNardo, K. Vockel, R. Sternglanz, DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication, Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 2616-2620.
21. [21] P. D'Arpa, L.F. Liu, Topoisomerase-targeting antitumor drugs, Biochim. Biophys. Acta 989 (1989) 163-177.
22. [22] J.R. Spitzner, I.K. Chung, M.T. Muller, Eukaryotic topoisomerase II preferentially cleaves alternating purine-pyrimidine repeats, Nucleic Acids Res. 18 (1990) 1-11.
23. [23] M.T. Muller, V.B. Mehta, DNase I hypersensitivity is independent of endogenous topoisomerase II activity during chicken erythrocyte differentiation, Mol. Cell. Biol. 8 (1988) 3661-3669.
24. [24] D. Subramanian, E. Kraut, A. Staubus, D.C. Young, M.T. Muller, Analysis of topoisomerase I/DNA complexes in patients administered topothecan, Cancer Res. 55 (1995) 2097-2103.
25. [25] D.K. Trask, J.A. DiDonato, M.T. Muller, Rapid detection and isolation of covalent DNA/protein complexes: application to topoisomerase I and II, EMBO J. 3 (1984) 671-676.
26. [26] J.R. Spitzner, M.T. Muller, A consensus sequence for cleavage by vertebrate DNA topoisomerase II, Nucleic Acids Res. 16 (1988) 5533-5556.
27. [27] I.K. Chung, V.B. Mehta, J.R. Spitzner, M.T. Muller, Eukaryotic topoisomerase II cleavage of parallel stranded DNA tetraplexes, Nucleic Acids Res. 20 (1992) 1973-1977.
28. [28] E.L. Zechiedrich, N. Osheroff, Eukaryotic topoisomerases recognize nucleic acid topology by preferentially interacting with DNA crossovers, EMBO J. 9 (1990) 4555-4562.
29. [29] J.R. Spitzner, I.K. Chung, T.D. Gootz, P.R. McGuirk, M.T. Muller, Analysis of eukaryotic topoisomerase II cleavage site in the presence of the quinolone CP-115,953 reveals drug-dependent and independent recognition elements, Mol. Pharmacol. 48 (1995) 238-249.
30. [30] G.K. Capranico, W. Kohn, Y. Pommier, Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin, Nucleic Acids Res. 18 (1990) 6611-6619.
31. [31] M.T. Muller, J.R. Spitzner, J.A. DiDonato, V.B. Mehta, K. Tsutsui, Single-strand DNA cleavages by eukaryotic topoisomerase II, Biochemistry 27 (1988) 8369-8379.
32. [32] W.R.A. Brown, P.J. MacKinnon, A. Villasant, N. Spurr, V.J. Buckle, M.J. Dobson, Structure and polymorphism of human telomere-associated DNA, Cell 63 (1990) 119-132.
33. [33] T. de Lange, L. Shiue, R.M. Myers, S.L. Cox, S.L. Naylor, A.M. Killery, H.E. Varmus, Structure and variability of human chromosome ends, Mol. Cell. Biol. 10 (1990) 518-527.
34. [34] Y. Adachi, E. Kas, U.K. Laemmli, Preferential, cooperative binding of DNA topoisomerase II to scaffold-associated regions, EMBO J. 8 (1989) 3997-4006.
35. [35] A. Udvardy, P. Schedl, Chromatin structure, not DNA sequence specificity, is the primary determinant of topoisomerase II of action in vivo, Mol. Cell. Biol. 11 (1991) 4973-4984.
36. [36] H. Tommerup, A. Dousmanis, T. de Lange, Unusual chromatin in human telomeres, Mol. Cell. Biol. 14 (1994) 5777-5785.
37. [37] Y. Pommier, G. Capranico, A. Orr, K.W. Kohn, Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide, Nucleic Acids Res. 19 (1991) 5973-5980.
38. [38] P. Fosse, R. Brigitte, M. Le Bret, C. Paoletti, J.M. Saucier, Sequence requirements for mammalian topoisomerase II mediated DNA cleavage stimulated by a ellipticine derivative, Nucleic Acids Res. 19 (1991) 2861-2868.
39. [39] Y. Pommier, F. Leteurtre, M.R. Fesen, A. Fujimori, R. Bertrand, E. Solary, G.K. Kohlhagen, K.W. Kohn, Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors, Cancer Invest. 12 (1994) 530-542.
40. [40] T. Uemura, H. Ohkura, Y. Adachi, K. Morino, K. Shiozaki, M. Yanagida, DNA topoisomerase II is required for condensation and separation of mitotic chromosome in S. pombe, Cell 50 (1987) 917-925.
41. [41] J.W. Phillips, W.F. Morgan, Illegitimate recombination induced by DNA double-strand breaks in a mammalian chromosome, Mol. Cell. Biol. 14 (1994) 5794-5803.